Cargando…
A novel 4-gene prognostic signature for hypermutated colorectal cancer
BACKGROUND: Hypermutated colorectal cancer (CRC) reportedly accounts for 15%–17% of all cases of CRC. However, the proportion and number of patients with hypermutated CRC cannot be unappreciated. Additionally, therapy options for these patients differ from those for CRC patients, with a greater pote...
Autores principales: | Ge, Weiting, Cai, Wen, Bai, Rui, Hu, Wangxiong, Wu, Dehao, Zheng, Shu, Hu, Hanguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407520/ https://www.ncbi.nlm.nih.gov/pubmed/30881123 http://dx.doi.org/10.2147/CMAR.S190963 |
Ejemplares similares
-
Deciphering molecular properties of hypermutated gastrointestinal cancer
por: Hu, Wangxiong, et al.
Publicado: (2018) -
Ultra‐mutated colorectal cancer patients with POLE driver mutations exhibit distinct clinical patterns
por: Hu, Hanguang, et al.
Publicado: (2020) -
Factors Affecting the Outcomes of Patients with Malignant Rhabdoid Tumors: A Population-Based Study
por: Cai, Wen, et al.
Publicado: (2021) -
Pan-cancer analyses demonstrate that ANKRD6 is associated with a poor prognosis and correlates with M2 macrophage infiltration in colon cancer
por: Bai, Rui, et al.
Publicado: (2021) -
Subtyping of microsatellite instability-high colorectal cancer
por: Hu, Wangxiong, et al.
Publicado: (2019)